6-Aminopenicillanic acid

6-Aminopenicillanic acid (CAS No.: 551-16-6) is a core β-lactam scaffold and parent amine that serves as a key biosynthetic and semisynthetic intermediate in the production of penicillin-derived antibiotics, typically generated through enzymatic hydrolysis of penicillin G by penicillin acylase. Functionally, it acts as an antibacterial agent by interfering with bacterial cell wall biosynthesis, primarily through inhibition of penicillin-binding proteins such as transpeptidases and dd-carboxypeptidases, thereby disrupting peptidoglycan crosslinking during cell division. This mechanism underlies its activity against a range of bacterial species, including Gram-negative organisms, and supports its relevance in studying resistance mechanisms and β-lactam pharmacology. In vitro studies of 6-aminopenicillanic acid derivatives and conjugates suggest inhibitory effects on bacterial enzymes at low micromolar to higher concentration ranges, depending on structural modifications and assay conditions. Widely utilized in medicinal chemistry and antibiotic development, this compound provides a versatile platform for the generation of novel β-lactam analogs and for probing penicillin-associated immune responses in cellular and biochemical models. Experimental applications span enzyme inhibition assays, bacterial culture systems, and preclinical investigations, where concentrations are adjusted according to specific study designs and therapeutic hypotheses.